Health ❯ Healthcare ❯ Cancer

Cancer Research

Clinical Trials Survival Rates Cancer Research UK Lung Cancer Immunotherapy Cancer Treatment Innovative Treatments Early Detection Cancer Therapeutics Awareness Initiatives Surgical Innovations Atlantic Cancer Research Institute Colon Cancer Dormancy Mechanisms Data Analysis Mortality Rates Patient Advocacy Health Policy Dietitian Advice World Cancer Research Day Advancements in Treatment Precision Oncology Regulatory T Cells Tumor Immunology Health-Related Quality of Life Cancers of Unknown Primary Drug Development Federal Grants Clinical Studies Funding Issues Vaping Risks Innovative Therapies Tumor Removal Surgery Collaborative Initiatives Molecular Oncology Trends in Cancer Research Epidemiology Minor Splicing Survivorship Cancer Advocacy Metastasis Treatment Centers Cancer Statistics Head and Neck Cancer Cancer Awareness Epidemiological Studies Targeted Therapy Merkel Cell Carcinoma Immunology European Cancer Centers Network Thymus and Cancer Risk Prevention Strategies Patient Support Royal Engagements National Cancer Institute Cancer Therapies Vaping and Cancer Data and Registries Health Equity Cancer Diagnosis Data Standardization Tumor Biology CAR T-cell Therapy Genomics Cancer Vaccines Genetic Testing

Study Finds Post-Diagnosis GLP-1 Use Linked to Lower Risk of Cancer Progression

Researchers say the association points to possible anti-tumor effects that require randomized trials and lab studies to test causation.

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

AI Uses DNA Methylation to Identify Primary Sites in Cancers of Unknown Primary

Greenebaum Family Foundation Gives $5.5 Million to University of Maryland Cancer Center

Grail’s Galleri Test Misses Main Goal in Large NHS Trial

Mayo Clinic Upgrades Orchestrate With OMOP Oncology to Standardize Cancer Data

U.S. Cancer Survival Hits 70% as ACS Warns Progress Is at Risk

U.S. Cancer Survival Reaches 70% in New ACS Report

MD Anderson, SOPHiA GENETICS Launch AI Partnership to Advance Precision Oncology

Adjuvant Pembrolizumab Cuts Risk of Distant Metastases in Merkel Cell Carcinoma at ESMO 2025

University of Calgary Launches National Toenail Study to Validate Radon Exposure Measure

AACR’s 2025 Report Shows Cancer Survival Gains as Early-Onset Cases Climb, Presses for Sustained U.S. Funding

Minor Splicing Inhibition Yields Drug Leads for KRAS-Driven Cancers

UCSF and Stanford Secure $100 Million Weill Matching Gift to Launch $200 Million West Coast Cancer Hub

Tumor Collagen Structure May Explain Racial Gaps in Cancer Prognosis

New UK study prompts National Cancer Plan to target childhood diagnosis delays